Ridesharing company

GeoPark Announces Fourth Quarter 2022 Operational Update

Retrieved on: 
Thursday, January 19, 2023
Oil, Gas, Energy, Carbon footprint, Public expenditure, Mariposa, EBITDA, Asset, Oriente, Hydrocarbon, Natural gas, Barco, Geopark, Injury, Certification, Adjustment, Share repurchase, Mirador, Platanillo, Gachetá, False equivalence, Airline, Renewable energy, Petroleum, Explosive, Ridesharing company

Production in 4Q2022 was affected by 15 days of localized blockades that impacted production and operations in the Llanos basin, combined with failures in electric submersible pumps in 12 wells since September 2022.

Key Points: 
  • Production in 4Q2022 was affected by 15 days of localized blockades that impacted production and operations in the Llanos basin, combined with failures in electric submersible pumps in 12 wells since September 2022.
  • Further testing activities are planned to continue in 1Q2023
    Llanos 94 Block (GeoPark non-operated, 50% WI)
    Humea 1 exploration well was spudded in October 2022 and reached a total depth of 11,350 feet.
  • Since late December 2022, net gas production in the Manati gas field has been reduced to 600-1,000 boepd.
  • GeoPark plans to release its 2022 year-end independent reserves certification by the end of January 2023 or early February 2023.

Uber Announces Date of Fourth Quarter 2022 Results Conference Call

Retrieved on: 
Wednesday, January 18, 2023
Transportation, Technology, Apps, Applications, Travel, Software, Uber, City, Regulation Fair Disclosure, Movement, Regulation, Disclosure, NYSE, Food, Ridesharing company

Uber Technologies, Inc. (NYSE: UBER) will hold its quarterly conference call to discuss its fourth quarter 2022 financial results on Wednesday, February 8th at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time).

Key Points: 
  • Uber Technologies, Inc. (NYSE: UBER) will hold its quarterly conference call to discuss its fourth quarter 2022 financial results on Wednesday, February 8th at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time).
  • A live webcast of the conference call and earnings release materials can be found on Uber’s Investor Relations website at investor.uber.com.
  • A replay of the conference call will be accessible for at least 90 days.
  • Accordingly, investors should monitor the company’s Investor Relations website, in addition to following the company’s press releases, SEC filings, public conference calls, presentations, and webcasts.

Discover® Global Network Launches Transit Solution Internationally

Retrieved on: 
Wednesday, January 18, 2023
Banking, Mobile, Wireless, Professional Services, Fintech, Public Transport, Transportation, Technology, Travel, Other Transport, Other Professional Services, Transport, Finance, New Taipei Metro, CDTA, Diners Club International, Pay, Meron Getnet, Discover Card, Discover, Seville Metro, ATM, Public Transport Corporation, Empresa Municipal de Transportes de Madrid, Tap, City, Global Television Network, Dallas Area Rapid Transit, CTA, Credentialing, Metro, Chicago Transit Authority, DART, Ridesharing company

Riders may now use their Discover, Diners Club International® and network alliance partner cards to make contactless payments at these transit agencies in top international destinations.

Key Points: 
  • Riders may now use their Discover, Diners Club International® and network alliance partner cards to make contactless payments at these transit agencies in top international destinations.
  • “The Discover® Transit Solution gives riders the flexibility to pay how they want and provides a seamless customer experience,” said Emily Foshee, vice president of core network products and delivery at Discover.
  • This ensures Discover® Global Network Cardholders have an enjoyable seamless experience when they visit," says Rubén Justel, CEO at Getnet Europe.
  • The Discover® Transit Solution enables acceptance of both traditional and contactless transit payments and offers customizable options including supporting merchant transit fare policies, pass products (credentialing), white labeling, contactless payments, first ride risk share and payment account reference.

Global In-Vehicle Payments Market Report to 2031 - Featuring IBM, Mastercard, P97 Networks, Sheeva.AI and Shell Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, January 16, 2023
Technology, Vehicle Technology, Payments, Automotive, CarPlay, Mastercard, Collection, General Motors, Region, OEM, Honda, Growth, PayPal, Urbanization, Visa, Gasoline, Coffee, Food, Car dealership, Online shopping, Ridesharing company

The global in-vehicle payments market is projected to reach $25,918.6 million by 2031 from $4,900.0 million in 2021, growing at a CAGR of 18.15% during the forecast period 2022-2031.

Key Points: 
  • The global in-vehicle payments market is projected to reach $25,918.6 million by 2031 from $4,900.0 million in 2021, growing at a CAGR of 18.15% during the forecast period 2022-2031.
  • For example, well-known automakers, including Honda, General Motors, Mercedes, and others, have already begun to offer in-vehicle payment services in recent years.
  • This shift in original equipment manufacturer (OEM) focus toward developing in-car payment services is expected to drive growth in the in-vehicle payments market in the coming years.
  • Debit and credit cards are the most popular payment methods and are widely used to make in-vehicle payments.

Views of 258 Neurology Patient Groups on the Corporate Reputation of Pharma in 2022 - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 12, 2023
Health, Other Health, Ranking, Roche, Pharma, Patient, Pharmaceutical industry, Fine chemical, Ridesharing company, Medical device, Generic drug, Neurology

The "The Corporate Reputation of Pharma in 2022 - The Patient Perspective - Neurology Edition: The Views of 258 Neurology Patient Groups" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "The Corporate Reputation of Pharma in 2022 - The Patient Perspective - Neurology Edition: The Views of 258 Neurology Patient Groups" report has been added to ResearchAndMarkets.com's offering.
  • Patient groups - and neurology patient groups especially - possess a deep and unique understanding of the patients they represent, and express the collated views of these patients.
  • The report provides details on:
    How the analyst measures pharma's corporate reputation from a patient perspective;
    The companies included in the 2021 neurology analyses;
    The headline results of the 2021 survey, from the perspective of neurology patient groups; and
    The profiles of 2021's respondent neurology patient groups.
  • Relationships that neurological patient groups have with pharma, 2021
    Industry-wide findings, according to respondent neurological patient groups, 2021
    Rankings of 20 pharma companies, 2021 v. 2020, as assessed by respondent neurological patient groups familiar with the companies
    Rankings of 12 pharma companies, 2021 v. 2020, as assessed by respondent neurological patient groups working with the companies
    Rankings of 11 'big-pharma' companies, 2021 v. 2020, as assessed by respondent neurological patient groups familiar with the companies
    Rankings of 6 'big-pharma' companies in Neurological, 2021 v. 2020, as assessed by respondent neurological patient groups working with the companies
    Profiles of the 20 companies, 2021 (v. 2020)
    I. Profiles of respondent neurological patient groups, 2021
    II.

TransLink customers can now tap with Interac Debit

Retrieved on: 
Wednesday, January 11, 2023
Technology, Finance, Fintech, Banking, Business, Professional Services, Other Transport, Trucking, Rail, Transport, Personal Finance, Digital Cash Management, Digital Assets, Payments, Logistics, Supply Chain Management, Public Transport, Compass card (British Columbia), Transit, Interac, Translink, Senior, Smartphone, National Partnership Office, Metro, Coffee, Cubic Transportation Systems, Debits and credits, Payment card, Online shopping, Ridesharing company, Cryptocurrency, Metro Vancouver Regional District, Compass

TransLink customers can now pay for transit using Interac® Debit on every bus and at every fare gate throughout Metro Vancouver.

Key Points: 
  • TransLink customers can now pay for transit using Interac® Debit on every bus and at every fare gate throughout Metro Vancouver.
  • This makes TransLink the first transit agency in Canada to fully integrate contactless Interac Debit payments systemwide.
  • The upgrade allows customers to board transit by using Interac Debit with physical cards or through smartphone digital wallets.
  • Interac Debit payments is one more addition to the suite of available payment options for TransLink customers.

The Worldwide Ride Hailing Services Industry is Expected to Reach $104.9 Billion by 2030 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 11, 2023
Internet, Fleet Management, Mobile, Wireless, Technology, Automotive, Transport, Sustainable development, Consumer, International Institute for Environment and Development, University, Government, Climate change, Friends, Ministry, Internet, Environment, Smartphone, Uber, Maintenance, Organization, CO2, City, Rural area, Chapter Three, Paris, Feedback, Ola, Ridesharing company, Renewable energy, Growth

Large number of operators offering offline channels for booking a ride and consumer behavior are attributed for the higher market share of the ride hailing services in the global market.

Key Points: 
  • Large number of operators offering offline channels for booking a ride and consumer behavior are attributed for the higher market share of the ride hailing services in the global market.
  • Offline channels have been widely used for the booking a ride with transportation network companies and taxi companies by phone or travel agents.
  • Increasing affordability of smartphone and internet penetration is rising the dependency on the digital solutions across various industries, including ride-hailing services.
  • Ride Hailing Services Market Variables, Trends & Scope

Antitrust Violation vs. Injury-in-Fact: A distinction that makes a difference

Retrieved on: 
Saturday, February 4, 2023
Nexium, Laboratory, Supreme, Character, Ranbaxy Laboratories, AstraZeneca, Actavis, Government, Risk, Law of the United Kingdom, Policy, United States Court of Appeals for the First Circuit, Esomeprazole, Patent, Pharmacy, District of Columbia Court of Appeals v. Feldman, Supreme court, FTC, Ridesharing company

But private plaintiffs must make an additional showing: to establish antitrust ‘standing,’ private plaintiffs must prove that the antitrust violation caused harm to them.

Key Points: 
  • But private plaintiffs must make an additional showing: to establish antitrust ‘standing,’ private plaintiffs must prove that the antitrust violation caused harm to them.
  • This distinction is deeply rooted in our system of antitrust enforcement, which permits many types of enforcers but limits standing to those with a cognizable claim of injury.
  • But when courts and litigants miss this doctrinal distinction on the road to resolving a case, it can have significant implications for antitrust law and policy.
  • The brief takes no position on the merits of the case, but instead explains that the district court missed the important distinction between an antitrust violation and an injury-in-fact.

Patient Perspective of the Corporate Reputation of Pharma Companies, 2021-2022: Boehringer Ingelheim Ranked 1st, Sanofi 2nd and Pfizer Ranked 3rd

Retrieved on: 
Friday, January 13, 2023
Pharmacist, Janssen, Ranking, Acute exacerbation of chronic obstructive pulmonary disease, Reputation, Suggestion, State, Edition, Health, Stockholm Environment Institute US Center, Pharma, Centers for Disease Control and Prevention, AstraZeneca, Boehringer Ingelheim, Patient, COPD, COVID-19, Excellent, Medical device, Animal, Medical imaging, Fine chemical, Pharmaceutical industry, Generic drug, Ridesharing company, Pfizer

The top-three pharma companies out of 16 companies, ranked for their overall corporate reputation in 2021, as assessed by respondent respiratory-conditions patient groups familiar with the company: Boehringer Ingelheim, 1st - Sanofi, 2nd - Pfizer, 3rd.

Key Points: 
  • The top-three pharma companies out of 16 companies, ranked for their overall corporate reputation in 2021, as assessed by respondent respiratory-conditions patient groups familiar with the company: Boehringer Ingelheim, 1st - Sanofi, 2nd - Pfizer, 3rd.
  • The top-three pharma companies out of 10 companies, ranked for their overall corporate reputation in 2021, as assessed by respondent respiratory-conditions patient groups working with the company: Janssen, 1st - Sanofi, 2nd - Boehringer Ingelheim, 3rd.
  • The top-three 'big-pharma' pharma companies out of 8 companies, ranked for their overall corporate reputation in 2021, assessed by respondent respiratory-conditions patient groups working with the company: Janssen, 1st - Sanofi, 2nd - Roche, 3rd.
  • Commentaries and feedback from respondent respiratory-conditions patient groups on how pharma can improve, 2021-2022
    Profiles of the 16 companies, 2021

MARK ODORICO, File No. 2022-18

Retrieved on: 
Thursday, January 12, 2023
Order, Tribunal, Mail order, Clothing, Ridesharing company

TORONTO, Jan. 12, 2023 /CNW/ - The Tribunal issued an Order in the above named matter.

Key Points: 

TORONTO, Jan. 12, 2023 /CNW/ - The Tribunal issued an Order in the above named matter.
A copy of the Order dated January 12, 2023 is available at capitalmarketstribunal.ca